Avirmax Inc., will make three scientific presentations at the 2025 Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Salt Lake City, Utah, May 4 - 8, 2025. ARVO is the ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

ProBio, a global contract development and manufacturing organization (CDMO), announced that it will present six poster presentations at the American Society of Gene and Cell Therapy (ASGCT) 28th ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...